$CSBR SEC Filings

Filed On	Filing
16 Oct 2026	Form 4: Ackerman Joel, Director Received 69,794 shares by exercise or conversion ($112K)
16 Oct 2026	8-K: Submission of Matters to a Vote of Security Holders On October 14, 2026, Champions Oncology, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results...
11 Sep 2026	10-Q
10 Sep 2026	8-K: Results of Operations and Financial Condition One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104
28 Aug 2026	DEFA14A
28 Aug 2026	Proxy statement: annual meeting on October 14, 2026 CEO pay $3.6M · say-on-pay vote
27 Jul 2026	10-K
27 Jul 2026	8-K: Results of Operations and Financial Condition
30 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Mar 2026	10-Q
12 Mar 2026	8-K: Results of Operations and Financial Condition
30 Jan 2026	Form 4: Brainin Robert Lawrence, Director Granted 700,000 Option to purchase Common Stock ($5.46M)
30 Jan 2026	Form 4: Brainin Robert Lawrence, Director Granted 9,901 Option to purchase Common Stock ($100K) · Granted 14,130 Option to purchase Common Stock ($98.9K) · Granted 19,070 Option to purchase Common Stock ($105K) · 1 more
16 Jan 2026	Form 3: Brainin Robert Lawrence, Director
15 Dec 2025	10-Q
15 Dec 2025	8-K: Results of Operations and Financial Condition
07 Nov 2025	Form 4: Breitfeld Philip P., Director Granted 13,790 Option to purchase Common Stock ($93.8K)
07 Nov 2025	Form 4: Sidransky David, Director Granted 21,216 Option to purchase Common Stock ($144K)
07 Nov 2025	Form 4: Mendelson Daniel Newman, Director Granted 13,790 Option to purchase Common Stock ($93.8K)
07 Nov 2025	Form 4: Tobin Scott R, Director Granted 25,460 Option to purchase Common Stock ($173K)

Comments